Multimodality Strategies Including Surgery in HER2-Positive and Negative Esophagogastric Adenocarcinoma With Brain Metastasis

18 Dec 2023 05:00 06:30
Zurich
Schneider Paul Magnus Host

Introduction Lectures

  • Alexander Siebenhuener: Targeting HER2 and tumor microenvironment in esophagogastric adenocarcinoma.

  • Stefan P. Moenig: Surgical treatment options in oligometastatic esophagogastric adenocarcinoma.

Case 1: HER2-Positive Adenocarcinoma With Multiple Brain Metastases

Presenter of the Case

Olga Meier

  • Diagnosis: HER2-positive adenocarcinoma in a long segment Barrett’s esophagus (C6, M8).

  • Brain Metastases: Multiple (5) brain metastases.

  • ID: 01/2016.

Case 2: HER2-Negative Adenocarcinoma With Solitary Brain Metastasis

Presenter of the Case

Jonas Ehrsam

  • Diagnosis: HER2-negative adenocarcinoma of the EG junction, Siewert type I.

  • Brain Metastasis: Single asymptomatic brain metastasis.

  • ID: 06/2023.

Topics for Discussion

  1. Tumor microenvironment in esophagogastric adenocarcinomas

  2. Multimodality treatment

  3. Markers

  4. Current immunotherapy